Biomarker and Immunogenicity Support for Biologics Development
Anapharm Bioanalytics - Anapharm Europe S.L.U.
Service ID:
EP391S3This service provides specialised bioanalytical support for biologics development programmes requiring pharmacokinetic (PK), biomarker and immunogenicity assessment during preclinical and clinical stages. The service includes support for pharmacokinetic (PK), anti-drug antibody (ADA), neutralising antibody (NAb), pharmacodynamic (PD) and biomarker analysis using ligand-binding assay platforms and cell-based assays adapted to the specific characteristics of each biologic programme. The objective of the service is to support innovators in understanding biological activity, immunogenicity profile and treatment response while generating high-quality data to support development decisions and regulatory interactions. Activities may include assay development, optimisation, qualification and sample analysis strategies adapted to exploratory or regulated environments. The service combines scientific expertise, regulatory awareness and flexible collaboration models particularly suited for innovative and early-stage biotech companies.
Services are offered on a fee-for-service basis. Pricing and project scope are defined individually according to the scientific and technical requirements of each biologics development programme. Costs may vary depending on assay format, analytical complexity, immunogenicity strategy, biomarker requirements, sample volume and development stage. Flexible collaboration approaches can be adapted to exploratory or regulated development environments.
Typical pricing ranges:
- Method Transfer / Qualification for non-regulated environments: approximately €10,000 – €15,000
- ADA Method Validation: approximately €60,000 – €80,000
- NAb Method Validation: approximately €50,000 – €70,000
- ADA Screening Sample Analysis: approximately €50 – €80 per sample
- ADA Confirmatory Sample Analysis: approximately €100 – €150 per sample
- NAb / Titer Sample Analysis: approximately €250 – €350 per sample
In addition, bioanalytical reporting activities typically range between approximately €3,500 – €7,000 depending on project complexity and reporting requirements.
Project scope, timelines and analytical strategies are defined according to the specific characteristics and complexity of each biologics development programme. Service execution is subject to laboratory capacity, assay requirements and availability of critical reagents and study materials.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project website.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.